• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Gracell Biotechnologies Inc ADR (NQ: GRCL )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Feb 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Gracell Biotechnologies Inc ADR

    < Previous 1 2 3 4 5 Next >
    Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets
    Inmagene Biopharma of Shanghai transferred 7.5% of its shares to HutchMed for global rights to two clinical stage immunology assets. It will also be responsible for up to $230 million in milestones. 
    Via Talk Markets
    Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
    In a significant development, the FDA is set to impose a classwide black box warning following its investigation into secondary T-cell cancers arising from the use of existing CAR-T therapies.  
    Via Benzinga
    Exposures Product Safety
    With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs
    Key Takeaways: AstraZeneca will acquire Chinese cell therapy maker Gracell for up to $1.2 billion, representing an 86% premium to the company’s pre-announcement share price 
    Via Benzinga
    Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
    Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. 
    Via Investor's Business Daily
    Health Care Company AstraZeneca Announces Acquisition of Gracell Biotechnologies
    Via Benzinga
    A Preview Of Gracell Biotechnologies's Earnings
    Via Benzinga
    Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal
    Shanghai’s Elpiscience Biopharma has formed a $1.7 billion collaboration with Japan’s Astellas Pharma to develop a novel bispecific macrophage engager, ES019, along with an unspecified program.... 
    Via Talk Markets
    Stock Market Ending 2023 On High Note; Tesla, Drug M&A In Focus: Weekly Review
    The major indexes boast big annual gains with the Dow at record highs. 
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    Investor Sentiment Improves; Dow Jumps Over 150 Points
    The CNN Money Fear and Greed index showed an increase in overall market sentiment, while the index remained in the "Extreme Greed" zone on Tuesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher
    U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.50% to 37,574.66 while the NASDAQ rose 0.50% to 15,068.50. The... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    The Latest Analyst Ratings for Gracell Biotechnologies
    Via Benzinga
    4 Analysts Have This to Say About Gracell Biotechnologies
    Via Benzinga
    Preview: Gracell Biotechnologies's Earnings
    Via Benzinga
    Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Crude Oil Rises Over 3%; US Home Prices Increase In October
    U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.34% to 37,511.87 while the NASDAQ rose 0.43% to 15,057.13. The... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Sentage Holdings Shares Are Trading Lower By 5%; Here Are 20 Stocks Moving Premarket
    Shares of Sentage Holdings Inc. (NASDAQ: SNTG) shares moved lower in pre-market trading following results for the six months ended June 30, 2023. 
    Via Benzinga
    US Stocks Set To Start Final Trading Week Of Year On Positive Note As Santa Claus Rally Gets Going: Analyst Confident Of Market Finishing Year At Highs
    Stocks appear on track to start Tuesday's session on a positive note amid positive expectations concerning interest rates and economy. 
    Via Benzinga
    AstraZeneca Bolsters Cell Therapy Pipeline With Over $1B Deal For China-Based Gracell Biotechnologies
    AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire Gracell Biotechnologies Inc (NASDAQ: GRCL), further strengthening AstraZeneca's cell therapy portfolio. 
    Via Benzinga
    Gracell Biotechnologies, Stratasys, Hollysys Automation Technologies And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
    U.S. stock futures were higher this morning, with the Dow Jones futures gaining more than 40 points on Tuesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/Divestments
    LianBio received a $465 million buyout offer from Tang Capital Management. In addition, Tang also offered shareholders a contingent value right for 80% of net proceeds from any license or divestment of... 
    Via Talk Markets
    Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Bitfarms And Other Big Stocks Moving Lower On Friday
    U.S. stocks traded mixed, with the Dow Jones gaining around 90 points on Friday. Shares of Bitfarms Ltd. (NASDAQ: BITF) shares fell sharply during Friday’s session after the company announced a C$60... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Earnings Scheduled For November 13, 2023
    Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023
    Via Benzinga
    Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
    While ANL's IPO dropped more than 25% on its first day, netting just under $60M, private placement made up the difference. Plus: Deals, financings, trials and approvals. 
    Via Talk Markets
    Topics Initial Public Offering
    Exposures Securities Market
    Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
    BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies... 
    Via Talk Markets
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.